United States Antimony
UAMY
3.72
-0.14
-3.63%
United States Antimony
US · UAMY
#3651 by market cap
3.72
-0.14
-3.63%
Live - 5344 symbols - heartbeat 19s ago
· 2026-10-08 10:11
Pre-market
3.80
-1.58%
After-hours
3.89
+0.78%
Overnight
3.85
-0.26%
- Market cap
- 556.77M
- P/E (TTM)i
- -28.62
- P/Bi
- 3.08
- EPSi
- -0.04
- Div yieldi
- 0.00%
- 52W posi
- 0%
Reader sentiment
Are you bullish or bearish on UAMY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.3 percentage points.
Institutional ownership
- Held by institutions
- 68.23% -0.33pp
- Institutions
- 281 -4
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund52.23%
Private Company7.63%
Hedge Fund5.09%
Individual/Insider5.06%
Public Company2.25%
Family Office/Trust0.47%
Insurance Company0.31%
Government Pension Fund0.25%
Other26.71%
Top holders as of 2026-06-30
BlackRock
7.58% · 11.35M sh
State Street Global Advisors
7.58% · 11.34M sh
T. Rowe Price Group, Inc.
6.70% · 10.03M sh
Van Eck Associates Corporation
5.72% · 8.56M sh
Vanguard Capital Management, LLC
4.30% · 6.43M sh
Estate Of John C. Lawrence
4.10% · 6.14M sh
Frontier Capital Management
2.87% · 4.30M sh
Geode Capital Management, LLC
2.19% · 3.28M sh
Gary Evans
1.73% · 2.59M sh
Davidson Kempner Capital Management LP
1.69% · 2.53M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 28 buys · 17 sells
| Name | Role | Stake |
|---|---|---|
| Gary Evans | Independent Chairperson | 1.73% |
| Lloyd Bardswich | Independent Director | 0.62% |
| Blaise Aguirre | Independent Director | 0.59% |
| Michael McManus | Independent Director | 0.42% |
| Richard Isaak | Senior Vice President | 0.23% |
| John Gustavsen | President | 0.22% |
| Joseph Carrabba | Independent Director | 0.13% |
| Jeffrey Fink | VP & GM of BRZ | 0.07% |
| Melissa Pagen | Senior Vice President of Corporate Development & Governmental Relations | 0.03% |
| Jon Marinelli | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-31 | Lloyd Bardswich | Independent Director | Open Market Acquisition | +20,000 | $4.64 |
| 2026-08-31 | Joseph Carrabba | Independent Director | Open Market Acquisition | +21,300 | $4.72 |
| 2026-08-30 | Blaise Aguirre | Independent Director | Open Market Acquisition | +1,400 | $5.04 |
| 2026-08-27 | Gary Evans | Independent Chairperson | Open Market Acquisition | +20,000 | $4.92 |
| 2026-06-14 | Jon Marinelli | Independent Director | Open Market Acquisition | +12,500 | $7.45 |
| 2026-06-01 | Richard Isaak | Senior Vice President | Sale to Issuer | -100,000 | $9.75 |
| 2026-04-01 | Lloyd Bardswich | Independent Director | Sale to Issuer | -59,872 | $8.98 |
| 2026-03-30 | Blaise Aguirre | Independent Director | Sale to Issuer | -27,000 | $8.20–8.26 |
| 2026-03-26 | Lloyd Bardswich | Independent Director | Sale to Issuer | -82,855 | $9.05–9.34 |
| 2026-03-26 | Blaise Aguirre | Independent Director | Sale to Issuer | -31,712 | $8.77–9.16 |
| 2026-03-25 | Richard Isaak | Senior Vice President | Sale to Issuer | -83,334 | $9.00–10.00 |
| 2026-03-24 | Gary Evans | Independent Chairperson | Sale to Issuer | -400,000 | $9.76–9.88 |
| 2026-03-24 | Lloyd Bardswich | Independent Director | Intent to Sell (Form 144) | -142,727 | $9.82 |
| 2026-03-24 | Jeffrey Fink | VP & GM of BRZ | Sale to Issuer | -34,055 | $8.91–10.00 |
| 2026-03-24 | Jeffrey Fink | VP & GM of BRZ | Intent to Sell (Form 144) | -4,055 | $10.00 |
| 2026-03-22 | Melissa Pagen | Senior Vice President of Corporate Development & Governmental Relations | Sale to Issuer | -89,004 | $9.14 |
| 2026-03-22 | Jeffrey Fink | VP & GM of BRZ | Intent to Sell (Form 144) | -10,000 | $8.91–9.11 |
| 2026-01-14 | Michael McManus | Independent Director | Other Acquisition | +6,635 | -- |
| 2026-01-14 | Michael McManus | Independent Director | Other Derivative Acquisition | +12,259 | $8.29 |
| 2026-01-14 | Gary Evans | Independent Chairperson | Other Derivative Acquisition | +304,524 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 10:11:22 · For reference only, not investment advice and not tailored to your situation.